Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point

Genetic,Research,And,Biotech,Science,Concept.,Human,Biology,And,Pharmaceutical

RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, creating an attractive entry point.

Bio-Techne reported fourth-quarter adjusted earnings of 53 cents. It beat the consensus of 50 cents. Sales reached $316.96 million, beating the consensus of $316 million.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.